1. Home
  2. EFC vs ARDX Comparison

EFC vs ARDX Comparison

Compare EFC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFC
  • ARDX
  • Stock Information
  • Founded
  • EFC 2007
  • ARDX 2007
  • Country
  • EFC United States
  • ARDX United States
  • Employees
  • EFC N/A
  • ARDX N/A
  • Industry
  • EFC Real Estate
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFC Finance
  • ARDX Health Care
  • Exchange
  • EFC Nasdaq
  • ARDX Nasdaq
  • Market Cap
  • EFC 1.1B
  • ARDX 1.2B
  • IPO Year
  • EFC 2010
  • ARDX 2014
  • Fundamental
  • Price
  • EFC $12.55
  • ARDX $5.01
  • Analyst Decision
  • EFC Buy
  • ARDX Buy
  • Analyst Count
  • EFC 4
  • ARDX 7
  • Target Price
  • EFC $13.58
  • ARDX $10.58
  • AVG Volume (30 Days)
  • EFC 1.1M
  • ARDX 5.3M
  • Earning Date
  • EFC 02-24-2025
  • ARDX 02-20-2025
  • Dividend Yield
  • EFC 12.43%
  • ARDX N/A
  • EPS Growth
  • EFC 21.68
  • ARDX N/A
  • EPS
  • EFC 1.32
  • ARDX N/A
  • Revenue
  • EFC $290,293,000.00
  • ARDX $251,849,000.00
  • Revenue This Year
  • EFC N/A
  • ARDX $168.07
  • Revenue Next Year
  • EFC $26.40
  • ARDX $16.66
  • P/E Ratio
  • EFC $9.54
  • ARDX N/A
  • Revenue Growth
  • EFC 12.72
  • ARDX 87.57
  • 52 Week Low
  • EFC $10.88
  • ARDX $4.32
  • 52 Week High
  • EFC $13.46
  • ARDX $10.13
  • Technical
  • Relative Strength Index (RSI)
  • EFC 63.17
  • ARDX 46.43
  • Support Level
  • EFC $11.91
  • ARDX $4.98
  • Resistance Level
  • EFC $12.32
  • ARDX $6.07
  • Average True Range (ATR)
  • EFC 0.17
  • ARDX 0.40
  • MACD
  • EFC 0.04
  • ARDX 0.02
  • Stochastic Oscillator
  • EFC 95.59
  • ARDX 27.15

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Share on Social Networks: